Amedisys (AMED) PT Raised to $125 at Cantor Fitzgerald

October 11, 2018 9:10 AM EDT
Get Alerts AMED Hot Sheet
Price: $114.95 --0%

Rating Summary:
    13 Buy, 8 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 19 | New: 10
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Cantor Fitzgerald analyst Joseph France raised the price target on Amedisys (NASDAQ: AMED) to $125.00 (from $117.00) while maintaining a Neutral rating. Cantor Fitzgerald increased 2019 estimates to reflect the accretive impact of the Compassionate Care acquisition on AMED's earnings.

Cantor Fitzgerald raised 2019 revenue estimate to $1.93 billion (from $1.75 billion), 2019 adjusted EBITDA estimate to $211 million (from $189 million), and 2019 adjusted EPS estimate to $4.05 (from $3.85).

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst PT Change

Related Entities

Cantor Fitzgerald, Earnings, Definitive Agreement